StockData
GH Research PLC logo

GH Research PLC (GHRS) stock

GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$18.27−0.48 (-2.56%)

Close on Nov 17, 2026Market cap $1.13BP/E –Yield –

GH Research enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

GH Research's enterprise value was $870.77M on Nov 11, 2026, against $637.64M a year earlier. Over the last 5 years it ranged from $111.57M to $1.50B, with a median of $456.09M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$870.77M+76.4%
2025Dec 31, 2025$493.66M+80.1%
2024Dec 31, 2024$274.14M+27.3%
2023Dec 29, 2023$215.28M+45.6%
2022Dec 30, 2022$147.83M-77.5%
2021Dec 31, 2021$655.73M–

More GH Research figures

See a number that looks wrong?